Courtney A Marsh1, Janet D Cragan2, C J Alverson2, Adolfo Correa3. 1. Department of Obstetrics and Gynecology, University of Kansas School of Medicine, Kansas City, KS. Electronic address: cmarsh2@kumc.edu. 2. National Center on Birth Defects and Developmental Disabilities (NCBDDD), Centers for Disease Control and Prevention (CDC), Atlanta, GA. 3. Rollins School of Public Health, Emory University, Atlanta, GA; Department of Medicine, University of Mississippi Medical Center, Jackson, MS.
Abstract
OBJECTIVE: We sought to assess maternal prenatal use of analgesics and risk of cardiovascular malformations (CVM) in the offspring. STUDY DESIGN: Data from the Baltimore-Washington Infant Study, a population-based case-control investigation of CVM, were used to examine selected isolated CVM diagnoses and maternal analgesic use during the periconceptional period (3 months before and after conception). We compared case and control infants on frequency of maternal use of analgesics and estimated adjusted odds ratios (adjORs) and 95% confidence intervals (CI) with logistic regression models for specific CVM phenotypes. RESULTS: Frequency of periconceptional use of any analgesic was 52% among control mothers and 53% among case mothers. Analyses by CVM diagnoses identified an association of tetralogy of Fallot with maternal acetaminophen use (adjOR, 1.6; 95% CI, 1.1-2.3) and dextrotransposition of the great arteries with intact ventricular septum with maternal nonsteroidal antiinflammatory drug use (adjOR, 3.2; 95% CI, 1.2-8.7). CONCLUSION: Analgesic use during the periconceptional period was not associated with CVM in the aggregate or with most phenotypes of CVM examined. Associations with 2 phenotypes of CVM may have occurred by chance. These findings warrant corroboration and further study, including further evaluation of the observed associations, the dose of analgesic taken, more specific timing of analgesic use, and indications for use.
OBJECTIVE: We sought to assess maternal prenatal use of analgesics and risk of cardiovascular malformations (CVM) in the offspring. STUDY DESIGN: Data from the Baltimore-Washington Infant Study, a population-based case-control investigation of CVM, were used to examine selected isolated CVM diagnoses and maternal analgesic use during the periconceptional period (3 months before and after conception). We compared case and control infants on frequency of maternal use of analgesics and estimated adjusted odds ratios (adjORs) and 95% confidence intervals (CI) with logistic regression models for specific CVM phenotypes. RESULTS: Frequency of periconceptional use of any analgesic was 52% among control mothers and 53% among case mothers. Analyses by CVM diagnoses identified an association of tetralogy of Fallot with maternal acetaminophen use (adjOR, 1.6; 95% CI, 1.1-2.3) and dextrotransposition of the great arteries with intact ventricular septum with maternal nonsteroidal antiinflammatory drug use (adjOR, 3.2; 95% CI, 1.2-8.7). CONCLUSION: Analgesic use during the periconceptional period was not associated with CVM in the aggregate or with most phenotypes of CVM examined. Associations with 2 phenotypes of CVM may have occurred by chance. These findings warrant corroboration and further study, including further evaluation of the observed associations, the dose of analgesic taken, more specific timing of analgesic use, and indications for use.
Authors: Jon C Cook; Catherine F Jacobson; Feng Gao; Melissa S Tassinari; Mark E Hurtt; John M DeSesso Journal: Birth Defects Res B Dev Reprod Toxicol Date: 2003-02
Authors: Mario A Cleves; Van H Savell; Sarika Raj; Weizhi Zhao; Adolfo Correa; Martha M Werler; Charlotte A Hobbs Journal: Birth Defects Res A Clin Mol Teratol Date: 2004-03
Authors: Julia D Interrante; Elizabeth C Ailes; Jennifer N Lind; Marlene Anderka; Marcia L Feldkamp; Martha M Werler; Lockwood G Taylor; James Trinidad; Suzanne M Gilboa; Cheryl S Broussard Journal: Ann Epidemiol Date: 2017-09-20 Impact factor: 3.797
Authors: Alexa C Bowie; Martha M Werler; Maria P Velez; Wenbin Li; Andi Camden; Astrid Guttmann; Susan B Brogly Journal: CMAJ Date: 2022-02-07 Impact factor: 8.262
Authors: Millissia Ben Maamar; Laurianne Lesné; Kristin Hennig; Christèle Desdoits-Lethimonier; Karen R Kilcoyne; Isabelle Coiffec; Antoine D Rolland; Cécile Chevrier; David M Kristensen; Vincent Lavoué; Jean-Philippe Antignac; Bruno Le Bizec; Nathalie Dejucq-Rainsford; Rod T Mitchell; Séverine Mazaud-Guittot; Bernard Jégou Journal: Sci Rep Date: 2017-03-10 Impact factor: 4.379
Authors: Susan B Brogly; Maria P Velez; Martha M Werler; Wenbin Li; Andi Camden; Astrid Guttmann Journal: Epidemiology Date: 2021-05-01 Impact factor: 4.860